Harrow: Daniel Kaufman reports 5.04% stake
Harrow, Inc. Schedule 13G reports that Daniel Kaufman beneficially owns 1,878,000 shares of Common Stock, representing 5.04% as of 03/10/2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Harrow, Inc. Schedule 13G reports that Daniel Kaufman beneficially owns 1,878,000 shares of Common Stock, representing 5.04% as of 03/10/2026.
The filing lists Kaufman’s sole voting and dispositive power over the 1,878,000 shares. The address and CUSIP are provided in the disclosure.
Insights
Beneficial owner files passive Schedule 13G showing a >5% stake.
Daniel Kaufman is reported as beneficial owner of 1,878,000 shares with sole voting and dispositive power, representing 5.04% as of 03/10/2026.
Schedule 13G is typically passive reporting; the filing does not state changes to voting agreements or plans. Subsequent filings would show any active purchases or sales.
Holding size is visible; trading implications depend on future disclosures.
The disclosure quantifies a 5.04% beneficial position (1,878,000 shares) and confirms sole vote/dispositive authority for Kaufman as of 03/10/2026.
Market impact or intent is not stated in this excerpt; any change in holdings would be reported in later filings.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Daniel Kaufman report in Harrow (HROW)?
What form was filed to disclose Daniel Kaufman’s holdings in HROW?
Where can investors find identifying details from the filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.